Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1650 USD | -11.58% |
|
-96.84% | -97.24% |
02-06 | BioXcel to Implement Reverse Stock Split; Shares Fall | MT |
02-05 | BioXcel Therapeutics Provides Clinical and Business Update | RE |
EPS & Dividend: BioXcel Therapeutics
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | -32.32 | -60.64 | -64.8 | -94.72 | -98.4 | -28.78 | -19.43 | -13.13 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 233.760 | 739.200 | 325.280 | 343.680 | 47.200 | 2.640 | 2.640 | 2.640 |
Nbr of stocks (in thousands) | 1,127 | 1,523 | 1,749 | 1,751 | 1,830 | 3,102 | 3,102 | - |
Announcement Date | 3/9/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/12/24 | - | - | - |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -

MarketScreener is also available in this country: United States.
Switch edition